Johnson & Johnson Innovative Medicine has announced that it intends to invest €580 million (approximately US$ 642 m.) in its Italian operations over the next five years, with €125 million (approximately US$ 138 m.) intended to support an increase in production capacity and the expansion of capabilities for the future.

The investment will focus on the company’s site in Latina, which is reportedly important for the company’s global supply chain network, with more than four billion tablets produced at the site every year across around 30 different products, and 97% of this exported globally.